Aceso Life Science Group Limited (Stock Code: 00474) reported no changes in its authorized share capital for January 2026, retaining a total of HKD 500,000,000, comprising 50,000,000,000 ordinary shares at a par value of HKD 0.01 each.

The total number of issued shares remained at 7,381,776,805, with no treasury shares reported. The company confirmed that it continued to meet the required public float threshold of 25% at the end of January 2026, in line with relevant listing rules and regulations.